Kynam Capital Management, LP 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 11:44 am Purchase |
2025-03-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Kynam Capital Management, LP | 4,700,000 5.760% |
4,700,000 (New Position) |
Filing |